Anemia
News
FDA grants breakthrough therapy designation for severe aplastic anemia drug
Eltrombopag, from Novartis, will get expedited review for first-line treatment of severe aplastic anemia. It is already approved as a second-line...
Conference Coverage
Clinic eases pediatric-adult transition in sickle cell disease
CONCORD, N.C. – Transitional programs could help teenage patients continue self-care and avoid risk behaviors.
Conference Coverage
Emerging sickle cell agents target new pathways
CONCORD, N.C. – There are a number of new drugs in the sickle cell disease pipeline, and researchers are investigating gene therapy using patients...
Conference Coverage
Dedicated sickle cell center offers roadmap for care
CONCORD, N.C. – The Georgia Comprehensive Sickle Cell Center includes a dedicated emergency room.
Latest News
Many years on metformin linked to anemia risk
LISBON – Why cumulative metformin use is associated with an increased risk of anemia is unclear, and needs to be investigated further, according...
News
L-glutamine to prevent sickle cell complications featured in FDA podcast
Hear the FDA’s DISCO account of the role of L-glutamine’s recent approval for the acute complications of sickle cell disease.
Conference Coverage
Folic acid fortification prevents millions of cases of anemia
A strong public health rationale for mandatory food fortification.
News
FDA panel backs licensure for epoetin alfa biosimilar
How could a new epoetin alfa biosimilar change care and what are some concerns?
News
FDA advisory committee supports L-glutamine for SCD
L-glutamine powder got the nod from the majority of the FDA’s Oncologic Drugs Advisory Committee for treatment of sickle cell disease.
From the Journals
Oral iron of no benefit in heart failure with iron deficiency
High-dose oral iron therapy doesn’t improve exercise capacity in the estimated 50% of patients with symptomatic heart failure who also have iron...
Conference Coverage
PPIs triple heart failure hospitalization risk in atrial fib patients
PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart...